Tag: increase

Singapore , July 01, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), is pleased to announce its acquisition of Pesticide Pest Control Pte. Ltd., a Singapore-based pest control company with over 30 years of operational history.

JAKARTA, Indonesia, July 01, 2025 (GLOBE NEWSWIRE) -- HR Asia Best Companies to Work for in Asia, owned by Business Media International, proudly honours 80 organizations that exemplify excellence in human capital strategy and workplace culture. This year’s ceremony arrives as Indonesian companies navigate critical challenges in talent retention, multigenerational workforce integration, and shifting employee expectations.

AB “Ignitis grupė” (hereinafter – the Group) informs that on 30 June, with the agreement of the Group’s Management Board, the Group’s subsidiaries UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) and AB “Ignitis gamyba” (hereinafter – Ignitis Gamyba) made final investment decisions on three battery energy storage system (hereinafter – BESS) projects in Lithuania, with a combined 291 MW power and 582 MWh storage capacity. The German company Rolls-Royce Solutions GmbH will provide the equipment and the integration services for all three BESS projects.

AB “Ignitis grupė” (hereinafter – the Group) informs that on 30 June, with the agreement of the Group’s Management Board, the Group’s subsidiaries UAB “Ignitis renewables” (hereinafter – Ignitis Renewables) and AB “Ignitis gamyba” (hereinafter – Ignitis Gamyba) made final investment decisions on three battery energy storage system (hereinafter – BESS) projects in Lithuania, with a combined 291 MW power and 582 MWh storage capacity. The German company Rolls-Royce Solutions GmbH will provide the equipment and the integration services for all three BESS projects.

LAUSANNE, Switzerland and COPENHAGEN, Denmark, July 01, 2025 (GLOBE NEWSWIRE) -- ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced that the first participant has been included in the company’s Phase 2 clinical trial of its lead candidate RPN-001 (leflutrozole), an orally administered aromatase inhibitor in development for the treatment of male infertility (https://clinicaltrials.gov/study/NCT06993155?term=Leflutrozole&rank=1).

Issy-les-Moulineaux, July 1, 2025 (7am)
Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)